These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31888518)

  • 1. Urban-rural disparities in treatment outcomes among recurrent TB cases in Southern Province, Zambia.
    Mutembo S; Mutanga JN; Musokotwane K; Kanene C; Dobbin K; Yao X; Li C; Marconi VC; Whalen CC
    BMC Infect Dis; 2019 Dec; 19(1):1087. PubMed ID: 31888518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: a secondary analysis of routine surveillance data.
    Nanzaluka FH; Chibuye S; Kasapo CC; Langa N; Nyimbili S; Moonga G; Kapata N; Kumar R; Chongwe G
    Pan Afr Med J; 2019; 32():159. PubMed ID: 31308862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical profile and outcomes of drug resistant tuberculosis in Central Province of Zambia.
    Chanda E
    BMC Infect Dis; 2024 Apr; 24(1):364. PubMed ID: 38556907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013.
    Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR
    PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?
    Kasapo CC; Chimzizi R; Simwanza SC; Mzyece J; Chizema E; Mariandyshev A; Lee HY; Harries AD; Kapata N
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):887-893. PubMed ID: 28786797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
    Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
    BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare provision for HIV co-infected tuberculosis patients in rural Zambia: an observational cohort study at primary care centers.
    Miyano S; Muvuma S; Ishikawa N; Endo H; Msiska C; Syakantu G
    BMC Health Serv Res; 2013 Oct; 13():397. PubMed ID: 24103082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    Harausz EP; Garcia-Prats AJ; Law S; Schaaf HS; Kredo T; Seddon JA; Menzies D; Turkova A; Achar J; Amanullah F; Barry P; Becerra M; Chan ED; Chan PC; Ioana Chiotan D; Crossa A; Drobac PC; Fairlie L; Falzon D; Flood J; Gegia M; Hicks RM; Isaakidis P; Kadri SM; Kampmann B; Madhi SA; Marais E; Mariandyshev A; Méndez-Echevarría A; Moore BK; Nargiza P; Ozere I; Padayatchi N; Ur-Rehman S; Rybak N; Santiago-Garcia B; Shah NS; Sharma S; Shim TS; Skrahina A; Soriano-Arandes A; van den Boom M; van der Werf MJ; van der Werf TS; Williams B; Yablokova E; Yim JJ; Furin J; Hesseling AC;
    PLoS Med; 2018 Jul; 15(7):e1002591. PubMed ID: 29995958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of HIV among adults with pulmonary TB at a population level in Zambia.
    Chanda-Kapata P; Kapata N; Klinkenberg E; Grobusch MP; Cobelens F
    BMC Infect Dis; 2017 Mar; 17(1):236. PubMed ID: 28356081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct clinical characteristics and helminth co-infections in adult tuberculosis patients from urban compared to rural Tanzania.
    Sikalengo G; Hella J; Mhimbira F; Rutaihwa LK; Bani F; Ndege R; Sasamalo M; Kamwela L; Said K; Mhalu G; Mlacha Y; Hatz C; Knopp S; Gagneux S; Reither K; Utzinger J; Tanner M; Letang E; Weisser M; Fenner L
    Infect Dis Poverty; 2018 Mar; 7(1):24. PubMed ID: 29580279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with mortality among laboratory-diagnosed drug-resistant tuberculosis patients on treatment, KwaZulu-Natal Province, 2017-2019.
    Phafane MP; Ngozo J; Radebe Z; Lutge E; Ebonwu J
    Pan Afr Med J; 2024; 47():181. PubMed ID: 39092023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
    van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
    Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and characteristics of drug-resistant tuberculosis in rural Shandong, China.
    Tao NN; He XC; Zhang XX; Liu Y; Yu CB; Li HC
    Int J Infect Dis; 2017 Dec; 65():8-14. PubMed ID: 28958922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of rural residence and HIV infection on poor tuberculosis treatment outcomes in a large urban hospital: a retrospective cohort analysis.
    Adamu AL; Aliyu MH; Galadanci NA; Musa BM; Lawan UM; Bashir U; Abubakar I
    Int J Equity Health; 2018 Jan; 17(1):4. PubMed ID: 29310659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Treatment Success Rates Among HIV-Infected Multidrug-Resistant Tuberculosis Patients After Expansion of Antiretroviral Therapy in Botswana, 2006-2013.
    Shin SS; Modongo C; Boyd R; Caiphus C; Kuate L; Kgwaadira B; Zetola NM
    J Acquir Immune Defic Syndr; 2017 Jan; 74(1):65-71. PubMed ID: 27552155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of rifampicin resistance tuberculosis among HIV/TB coinfected patients in Benue State, Nigeria.
    Ejeh FE; Undiandeye A; Okon K; Moshood KH
    Pan Afr Med J; 2021; 38():203. PubMed ID: 33995809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.
    Jones-López EC; Ayakaka I; Levin J; Reilly N; Mumbowa F; Dryden-Peterson S; Nyakoojo G; Fennelly K; Temple B; Nakubulwa S; Joloba ML; Okwera A; Eisenach KD; McNerney R; Elliott AM; Ellner JJ; Smith PG; Mugerwa RD
    PLoS Med; 2011 Mar; 8(3):e1000427. PubMed ID: 21423586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa.
    van der Walt M; Lancaster J; Shean K
    PLoS One; 2016; 11(3):e0144249. PubMed ID: 26950554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.